HeadlineShine

Small-cap stock under ₹50 jumps 7% despite weak trends on Dalal Street; here's why | Target price, stop-loss

MintSmall-cap stock under ₹50 jumps 7% despite weak trends on Dalal Street; here's why | Target price, stop-loss
Image: Mint

Sudarshan Pharma shares rose 7% on Wednesday after the company migrated from BSE’s SME platform to the NSE main board. Its board is scheduled to review Q2 FY27 results and a potential fundraising proposal on October 29.

Summary from Mint

Read the full story on Mint
React

More on Target

See all →

More business

See all →

Top stories in India

See all →